Skip to main content

Table 1 Clinical and laboratorial data of sample before and after the therapeutic intervention in all patients studied.

From: Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes

Variables Baseline 3 months Significance level
(p)
n (number) 51 51  
Gender(M/F) 19/32 19/32  
Age(years) 25,3 ± 1,55 25,3 ± 1,55  
Duration of diabetes (years) 11,31 ± 1,09 11,31 ± 1,09  
BMI (kg/m2) 22,87 ± 0,42 23,20 ± 0,47 0,51
sBP (mmHg) 111,3 ± 1,96
(180,0- 90,0)
111,24 ± 1,76
(180,0- 90,0)
0,81
sDP(mmhg) 70,24 ± 1,14
(90,0- 50,0)
90,03 ± 10,12
(100,0- 50,0)
0,32
A1c (%) 10,40 ± 0,33 9,52 ± 0,32 0,0009
A1c < 7% (n pacientes) 3 4  
Cholesterol(mg/dl) 174,88 ± 5,58 169,94 ± 4,58 0,23
HDL-Cholesterol(mg/dl)
LDL- Cholesterol(mg/dl)
53,84 ± 1,94
210,58 ± 6,05
53,40 ± 1,91
202,72 ± 4,86
0,79
0,11
Triglycerides (mg/d) 93,23 ± 7,60 104,63 ± 10,29 0,07
Fasting blood sugar
FBS (mg/dl)
180,00 ± 21,22 168,82 ± 14,79 0,73
Postprandial glycemia (mg/dl) 256,78 ± 12,82 243,39 ± 15,92 0,46
Insulin dose/kg 0,99 ± 0,65 1.05 ± 0.05 0,00
NPH insulin dose 55,08 ± 22,34 55,18 ± 21,10 0,89
Rapid insulin dose 4,42 ± 8,72 11,73 ± 7,04 0,00